Knowledge

Lysosomal acid lipase deficiency

Source đź“ť

2236: 2266: 2276: 50: 2256: 2246: 816: 407:
Depending on ethnicity and geography, prevalence has been estimated to be between 1 in 40,000 and 1 in 300,000; based on these estimates the disease may be underdiagnosed. Jewish infants of Iraqi or Iranian origin appear to be most at risk based on a study of a community in Los Angeles in which there
313:
Lysosomal acid lipase deficiencies occur when a person has defects (mutations) in both copies of the LIPA gene. Each parent of a person with LAL deficiency carries one copy of the defective LIPA gene. With every pregnancy, parents with a son or daughter affected by LAL deficiency have a 1 in 4 (25%)
346:
Because LAL deficiency is inherited, each sibling of an affected individual has a 25% chance of having pathological mutations in LAL genes from both their mother and their father, a 50% chance of having a pathological mutation in only one gene, and a 25% chance of having no pathological mutations.
398:
Infants with LAL deficiencies typically show signs of disease in the first weeks of life and if untreated, die within 6–12 months due to multi-organ failure. Older children or adults with LAL-D may remain undiagnosed or be misdiagnosed until they die early from a heart attack or stroke or die
379:
Before the drug was approved, treatment of infants was mainly focused on reducing specific complications and was provided in specialized centers. Specific interventions for infants included changing from breast or normal bottle formula to a specialized low fat formula, intravenous feeding,
337:
Liver biopsy findings will generally show a bright yellow-orange color, enlarged, lipid-laden hepatocytes and Kupffer cells, microvesicular and macrovesicular steatosis, fibrosis, and cirrhosis. The only definitive tests are genetic, which may be conducted in any number of ways.
445:, was approved in the US and EU for the treatment of human LAL enzyme deficiency. Before the approval of that drug, as of 2009 the two oldest survivors of LAL-D in the world were then aged 4 and 11; both of them had been treated with hematopoietic stem cell treatment. 947:
Tolar, J.; Petryk, A.; Khan, K.; Bjoraker, K. J.; Jessurun, J.; Dolan, M.; Kivisto, T.; Charnas, L.; Shapiro, E. G. (2009-01-01). "Long-term metabolic, endocrine, and neuropsychological outcome of hematopoietic cell transplantation for Wolman disease".
305:
that the body can reuse; when LAL doesn't function, cholesteryl esters and triglycerides build up in the liver, spleen and other organs. The accumulation of fat in the walls of the gut and other organs in leads to serious digestive problems including
420:, along with two other doctors, published the first case study of a LAL deficiency in a child born to closely related Persian Jews; 12 years later a case study on an older boy was published, which turned out to be the first case study of LAL-D. 399:
suddenly of liver failure. The first enzyme replacement therapy was approved in 2015. In those clinical trials nine infants were followed for one year; 6 of them lived beyond one year. Older children and adults were followed for 36 weeks.
129:) in the body. Infants, children and adults that have LAL deficiency experience a range of serious health problems. The lack of the LAL enzyme can lead to a build-up of fatty material in a number of body organs including the 371:
of LAL that was approved in 2015 in the US and EU. The disease of LAL affects < 0.2 in 10,000 people in the EU. According to an estimate by a Barclays analyst, the drug will be priced at about US$ 375,000 per year.
512:
Reiner, Željko; Guardamagna, Ornella; Nair, Devaki; Soran, Handrean; Hovingh, Kees; Bertolini, Stefano; Jones, Simon; Ćorić, Marijana; Calandra, Sebastiano; Hamilton, John; Eagleton, Terence; Ros, Emilio (July 2014).
1037: 1018: 310:, a condition in which the gut fails to absorb nutrients and calories from food, persistent and often forceful vomiting, frequent diarrhea, foul-smelling and fatty stools (steatorrhea), and failure to grow. 375:
It is administered once a week via intraveneous infusion in people with rapidly progressing disease in the first six months of life. In people with less aggressive disease, it is given every other week.
222:
in about half of infants with LAL-D. Complications of LAL-D progress over time, eventually leading to life-threatening problems such as extremely low levels of circulating red blood cells (severe
233:
Older children or adults generally present with a wide range of signs and symptoms that overlap with other disorders. They may have diarrhoea, stomach pain, vomiting, or poor growth, a sign of
1133: 334:, including elevated total cholesterol, elevated low-density lipoprotein cholesterol, decreased high-density lipoprotein cholesterol and elevated serum transaminases. 206:
As the disease progresses in infants, increasing fat accumulation in the liver leads to other complications including yellowing of the skin and whites of the eyes (
253:, usually around their eyelids. The disease is often undiagnosed in adults. The person may have a history of premature cardiac disease or premature stroke. 782: 285:
protein (also called lysosomal acid lipase or LAL), that results in a loss of the protein's normal function. When LAL functions normally, it breaks down
17: 1160: 880: 386:
were used in people with LAL-D prior to the approval of sebelipase alfa; they helped control cholesterol but did not appear to slow liver damage;
314:
chance of having another affected child. A person born with defects in both LIPA genes is not able to produce adequate amounts of the LAL enzyme.
148:
Very low levels of the LAL enzyme lead to LAL deficiency. LAL deficiency typically affects infants in the first year of life. The accumulation of
164:
from food. Because of these digestive complications, affected infants usually fail to grow and gain weight at the expected rate for their age (
675:. 2015 Jul 30. In: Pagon RA, Adam MP, Ardinger HH, et al., editors. GeneReviews . Seattle (WA): University of Washington, Seattle; 1993-2016. 647: 461:, to try to prevent the disease from getting worse. Data are sparse but there is a known high risk of serious complications including death, 1138: 355:
of pregnancies for women who are at increased risk are possible if family members carrying pathological mutations have been identified.
1765: 1297: 2315: 2106: 1405: 1705: 454: 2310: 1153: 2005: 1052: 179:
Until 2015, there was no treatment, and very few infants with LAL-D survived beyond the first year of life. In 2015, an
2141: 1483: 1436: 2305: 1302: 1177: 1146: 687:"Cholesteryl ester storage disease: Review of the findings in 135 reported patients with an underdiagnosed disease" 434:
Around 2010 both presentations have come to be known as LAL-D, as both are due to a deficiency of the LAL enzyme.
1410: 2259: 2131: 1565: 1431: 1397: 1243: 786: 1352: 812: 331: 2111: 1347: 1168: 1103: 925: 598: 1755: 686: 380:
antibiotics for infections, and steroid replacement therapy because of concerns about adrenal function.
1735: 1173: 438: 270: 180: 110: 2164: 1169: 515:"Lysosomal acid lipase deficiency – An under-recognized cause of dyslipidaemia and liver dysfunction" 462: 274: 599:"Lysosomal acid lipase deficiency--an under-recognized cause of dyslipidaemia and liver dysfunction" 1956: 1878: 1873: 1793: 1553: 1293: 1063: 1936: 1910: 294: 2300: 1528: 1476: 1450: 1181: 845:
Abramov A, Schorr S, Wolman M (Mar 1956). "Generalized xanthomatosis with calcified adrenals".
458: 2179: 2065: 2038: 2011: 1963: 1917: 1612: 1263: 1238: 874: 387: 368: 152:
in the walls of the gut in early onset disease leads to serious digestive problems including
2199: 2159: 2026: 1840: 1835: 1815: 1750: 1602: 1312: 200: 615: 531: 514: 8: 2279: 2221: 2204: 1863: 1580: 1041: 926:"FDA approves first drug to treat a rare enzyme disorder in pediatric and adult patients" 858: 266: 107: 58: 685:
Bernstein, Donna L.; HĂĽlkova, Helena; Bialer, Martin G.; Desnick, Robert J. (Jun 2013).
2169: 2126: 2116: 1905: 1858: 1825: 1820: 1570: 1548: 1357: 1229: 1224: 981: 352: 286: 1046: 2265: 2239: 2121: 2091: 2070: 2033: 2016: 1931: 1895: 1885: 1780: 1700: 1644: 1607: 1592: 1533: 1500: 1469: 1074: 973: 965: 862: 759: 708: 630: 546: 169: 165: 122: 70: 985: 2249: 1941: 1926: 1803: 1678: 1634: 1308: 1233: 1190: 957: 907: 854: 749: 739: 698: 620: 610: 536: 526: 482: 302: 282: 114: 75: 895: 2269: 2214: 2075: 2060: 2043: 1983: 1978: 1922: 1900: 1597: 1543: 1523: 1068: 911: 442: 364: 348: 262: 184: 672: 199:
Infants may present with feeding difficulties with frequent vomiting, diarrhea,
2101: 2055: 1868: 1798: 1617: 1444: 1415: 1383: 1361: 1333: 1211: 1079: 833: 828: 703: 1031: 1027: 2294: 2184: 1973: 1968: 1830: 1770: 1673: 1286: 1278: 1267: 969: 430:
Cholesteryl Ester Storage Disease, presenting in pediatric and adult patients
327: 307: 290: 234: 219: 215: 173: 153: 2189: 2174: 2000: 1725: 1575: 1560: 1506: 1328: 977: 866: 763: 712: 550: 417: 246: 142: 126: 744: 727: 634: 187:, was approved in the US and EU. The therapy was additionally approved in 2048: 1993: 1890: 1745: 1720: 1538: 1371: 1220: 1206: 961: 754: 298: 250: 242: 238: 62: 1010: 728:"A Phase 3 Trial of Sebelipase Alfa in Lysosomal Acid Lipase Deficiency" 2136: 2021: 1988: 1760: 1710: 1695: 1690: 1683: 1668: 1658: 625: 541: 211: 121:. This enzyme plays an important role in breaking down fatty material ( 79: 2209: 1951: 1946: 1810: 1788: 1663: 1627: 1343: 1323: 1255: 138: 1715: 1492: 1379: 1195: 1098: 227: 207: 157: 2194: 1654: 1622: 1515: 453:
Some children with LAL-D have had an experimental therapy called
383: 323: 161: 1128: 1123: 1057: 49: 1022: 223: 134: 118: 423:
LAL-D was historically referred to as two separate disorders:
844: 684: 241:, like itchiness, jaundice, pale stool, or dark urine. Their 188: 130: 1117: 168:). As the disease progresses, it can cause life-threatening 1461: 511: 149: 946: 226:), liver dysfunction or failure, and physical wasting ( 203:, and failure to gain weight or sometimes weight loss. 896:"Newly recognized disorders of cholesterol metabolism" 815:
Last updated Dec 2015. See FDA index page for labels
113:
that results in the body not producing enough active
1000: 214:
examination shows accumulation of chalky material (
1134:Lipid Storage Diseases Fact Sheet at ninds.nih.gov 1129:Article - LYSOSOMAL ACID LIPASE DEFICIENCY/NIH.gov 726:Burton, B. K.; et al. (September 10, 2015). 667: 665: 663: 661: 659: 657: 655: 330:are generally similar to people with more common 2292: 592: 590: 588: 586: 584: 582: 580: 578: 576: 574: 572: 570: 568: 566: 564: 562: 560: 277:. The condition is caused by a mutation of the 156:, a condition in which the gut fails to absorb 893: 652: 1477: 1154: 783:"New Drugs Online Report for sebelipase alfa" 725: 427:Wolman disease, presenting in infant patients 251:yellowish deposits of fat underneath the skin 879:: CS1 maint: multiple names: authors list ( 648:Learning Radiology.com Adrenal calcification 557: 1766:Reproductive endocrinology and infertility 1484: 1470: 1161: 1147: 785:. UK Medicines Information. Archived from 48: 2107:Bachelor of Medicine, Bachelor of Surgery 753: 743: 702: 671:Hoffman EP, Barr ML, Giovanni MA, et al. 624: 614: 540: 530: 1118:National Organization for Rare Disorders 596: 210:), and a persistent low-grade fever. An 1124:Article - LYSOSOMAL ACID LIPASE/NIH.gov 808: 806: 804: 507: 505: 503: 455:hematopoietic stem cell transplantation 14: 2293: 777: 775: 773: 448: 261:Lysosomal acid lipase deficiency is a 1465: 1142: 616:10.1016/j.atherosclerosis.2014.04.003 532:10.1016/j.atherosclerosis.2014.04.003 194: 2245: 2006:Physical medicine and rehabilitation 859:10.1001/archpedi.1956.02060020284010 801: 678: 500: 2255: 770: 363:LAL deficiency can be treated with 24: 18:Cholesterol esterification disorder 2142:Medical Scientist Training Program 940: 597:Reiner Ĺ˝; et al. (Jul 2014). 25: 2327: 1437:Cholesteryl ester storage disease 996: 2316:Diseases named after discoverers 2274: 2264: 2254: 2244: 2235: 2234: 1441:Lysosomal acid lipase deficiency 673:Lysosomal Acid Lipase Deficiency 390:was necessary in most patients. 96:Lysosomal acid lipase deficiency 33:Lysosomal acid lipase deficiency 2275: 918: 887: 838: 821: 732:New England Journal of Medicine 408:was a prevalence of 1 in 4200. 402: 351:for family members and genetic 243:feces may be excessively greasy 2132:Doctor of Osteopathic Medicine 1566:Oral and maxillofacial surgery 1432:Cerebrotendinous xanthomatosis 719: 641: 475: 249:, liver disease, and may have 13: 1: 2311:Autosomal recessive disorders 1353:Multiple sulfatase deficiency 468: 358: 332:familial hypercholesterolemia 2112:Bachelor of Medical Sciences 1879:Neurosurgical anesthesiology 1491: 1348:Metachromatic leukodystrophy 912:10.7326/0003-4819-58-4-718_1 393: 341: 317: 145:and other important organs. 7: 1411:Jansky–Bielschowsky disease 950:Bone Marrow Transplantation 10: 2332: 1170:Lysosomal storage diseases 704:10.1016/j.jhep.2013.02.014 439:enzyme replacement therapy 411: 271:inborn error of metabolism 181:enzyme replacement therapy 111:inborn error of metabolism 2230: 2152: 2090: 1851: 1779: 1734: 1643: 1514: 1499: 1424: 1396: 1369: 1321: 1276: 1253: 1204: 1189: 1089: 1004: 463:graft-versus-host disease 275:lysosomal storage disease 237:. They may have signs of 85: 69: 56: 47: 37: 32: 2066:Transplantation medicine 1957:Clinical neurophysiology 1874:Obstetric anesthesiology 1794:Interventional radiology 1554:Digestive system surgery 281:gene, which encodes the 256: 2306:Lipid storage disorders 1937:Intensive care medicine 1911:Mass gathering medicine 1756:Maternal–fetal medicine 1182:Lipid storage disorders 928:. FDA. December 8, 2015 894:Fredrickson DS (1963). 487:Genetics Home Reference 295:low density lipoprotein 201:swelling of the abdomen 1529:Cardiothoracic surgery 1451:Sea-blue histiocytosis 459:bone marrow transplant 457:(HSCT), also known as 2180:Personalized medicine 2039:Reproductive medicine 1964:Occupational medicine 1918:Evolutionary medicine 1264:Globotriaosylceramide 813:Sebelipase alfa Label 745:10.1056/NEJMoa1501365 691:Journal of Hepatology 388:liver transplantation 322:Blood tests may show 115:lysosomal acid lipase 2200:Traditional medicine 2160:Alternative medicine 2027:Addiction psychiatry 1841:Transfusion medicine 1836:Medical microbiology 1751:Gynecologic oncology 1603:Reproductive surgery 1294:Niemann–Pick disease 962:10.1038/bmt.2008.273 297:particles into free 2222:History of medicine 2205:Veterinary medicine 2012:Preventive medicine 1864:Adolescent medicine 1706:Infectious diseases 449:Research directions 267:autosomal recessive 108:autosomal recessive 59:autosomal recessive 2170:Molecular oncology 2127:Doctor of Medicine 2117:Master of Medicine 2034:Radiation oncology 1906:Emergency medicine 1859:Addiction medicine 1826:Clinical chemistry 1821:Clinical pathology 1613:Transplant surgery 1571:Orthopedic surgery 1549:Colorectal surgery 1358:Galactocerebroside 1230:GM2 gangliosidoses 1225:GM1 gangliosidoses 1090:External resources 353:prenatal diagnosis 287:cholesteryl esters 245:. They often have 239:bile duct problems 195:Symptoms and signs 123:cholesteryl esters 2288: 2287: 2122:Master of Surgery 2086: 2085: 2071:Tropical medicine 2017:Prison healthcare 1932:Hospital medicine 1896:Disaster medicine 1886:Aviation medicine 1701:Hospital medicine 1608:Surgical oncology 1593:Pediatric surgery 1587: 1534:Endocrine surgery 1459: 1458: 1392: 1391: 1313:Gaucher's disease 1239:Tay–Sachs disease 1113: 1112: 738:(11): 1010–1020. 247:an enlarged liver 170:liver dysfunction 166:failure to thrive 141:, in the wall of 93: 92: 27:Medical condition 16:(Redirected from 2323: 2278: 2277: 2268: 2258: 2257: 2248: 2247: 2238: 2237: 1942:Medical genetics 1927:General practice 1804:Nuclear medicine 1679:Gastroenterology 1635:Vascular surgery 1585: 1512: 1511: 1486: 1479: 1472: 1463: 1462: 1309:Glucocerebroside 1298:SMPD1-associated 1234:Sandhoff disease 1202: 1201: 1191:Sphingolipidoses 1178:lipid metabolism 1163: 1156: 1149: 1140: 1139: 1002: 1001: 990: 989: 944: 938: 937: 935: 933: 922: 916: 915: 891: 885: 884: 878: 870: 842: 836: 825: 819: 810: 799: 798: 796: 794: 789:on March 4, 2016 779: 768: 767: 757: 747: 723: 717: 716: 706: 697:(6): 1230–1243. 682: 676: 669: 650: 645: 639: 638: 628: 618: 594: 555: 554: 544: 534: 509: 498: 497: 495: 494: 483:"Wolman disease" 479: 369:recombinant form 303:free fatty acids 283:lysosomal lipase 76:Medical Genetics 52: 30: 29: 21: 2331: 2330: 2326: 2325: 2324: 2322: 2321: 2320: 2291: 2290: 2289: 2284: 2226: 2215:Chief physician 2148: 2093: 2082: 2076:Travel medicine 2061:Sports medicine 2044:Sexual medicine 1984:Palliative care 1979:Pain management 1923:Family medicine 1901:Diving medicine 1847: 1775: 1737: 1730: 1646: 1639: 1598:Plastic surgery 1544:General surgery 1524:Cardiac surgery 1505: 1503: 1495: 1490: 1460: 1455: 1420: 1388: 1365: 1326: 1317: 1272: 1268:Fabry's disease 1249: 1209: 1193: 1185: 1167: 1114: 1109: 1108: 1085: 1084: 1013: 999: 994: 993: 945: 941: 931: 929: 924: 923: 919: 892: 888: 872: 871: 847:AMA J Dis Child 843: 839: 826: 822: 811: 802: 792: 790: 781: 780: 771: 724: 720: 683: 679: 670: 653: 646: 642: 603:Atherosclerosis 595: 558: 519:Atherosclerosis 510: 501: 492: 490: 481: 480: 476: 471: 451: 443:sebelipase alfa 414: 405: 396: 365:sebelipase alfa 361: 349:Genetic testing 344: 320: 263:genetic disease 259: 197: 185:sebelipase alfa 28: 23: 22: 15: 12: 11: 5: 2329: 2319: 2318: 2313: 2308: 2303: 2286: 2285: 2283: 2282: 2272: 2262: 2252: 2242: 2231: 2228: 2227: 2225: 2224: 2219: 2218: 2217: 2207: 2202: 2197: 2192: 2187: 2182: 2177: 2172: 2167: 2162: 2156: 2154: 2153:Related topics 2150: 2149: 2147: 2146: 2145: 2144: 2134: 2129: 2124: 2119: 2114: 2109: 2104: 2102:Medical school 2098: 2096: 2088: 2087: 2084: 2083: 2081: 2080: 2079: 2078: 2068: 2063: 2058: 2056:Sleep medicine 2053: 2052: 2051: 2041: 2036: 2031: 2030: 2029: 2019: 2014: 2009: 2003: 1998: 1997: 1996: 1986: 1981: 1976: 1971: 1966: 1961: 1960: 1959: 1949: 1944: 1939: 1934: 1929: 1920: 1915: 1914: 1913: 1903: 1898: 1893: 1888: 1883: 1882: 1881: 1876: 1869:Anesthesiology 1866: 1861: 1855: 1853: 1849: 1848: 1846: 1845: 1844: 1843: 1838: 1833: 1828: 1823: 1818: 1808: 1807: 1806: 1801: 1799:Neuroradiology 1796: 1785: 1783: 1777: 1776: 1774: 1773: 1768: 1763: 1758: 1753: 1748: 1742: 1740: 1736:Obstetrics and 1732: 1731: 1729: 1728: 1723: 1718: 1713: 1708: 1703: 1698: 1693: 1688: 1687: 1686: 1676: 1671: 1666: 1661: 1651: 1649: 1641: 1640: 1638: 1637: 1632: 1631: 1630: 1620: 1618:Trauma surgery 1615: 1610: 1605: 1600: 1595: 1590: 1589: 1588: 1581:Otolaryngology 1578: 1573: 1568: 1563: 1558: 1557: 1556: 1551: 1541: 1536: 1531: 1526: 1520: 1518: 1509: 1507:subspecialties 1497: 1496: 1489: 1488: 1481: 1474: 1466: 1457: 1456: 1454: 1453: 1448: 1445:Wolman disease 1434: 1428: 1426: 1422: 1421: 1419: 1418: 1416:Batten disease 1413: 1408: 1402: 1400: 1394: 1393: 1390: 1389: 1387: 1386: 1384:Farber disease 1376: 1374: 1367: 1366: 1364: 1362:Krabbe disease 1355: 1350: 1341: 1339: 1338: 1337: 1334:leukodystrophy 1319: 1318: 1316: 1315: 1306: 1300: 1283: 1281: 1274: 1273: 1271: 1270: 1260: 1258: 1251: 1250: 1248: 1247: 1241: 1236: 1227: 1217: 1215: 1212:gangliosidoses 1199: 1187: 1186: 1166: 1165: 1158: 1151: 1143: 1137: 1136: 1131: 1126: 1121: 1111: 1110: 1107: 1106: 1094: 1093: 1091: 1087: 1086: 1083: 1082: 1071: 1060: 1049: 1034: 1014: 1009: 1008: 1006: 1005:Classification 998: 997:External links 995: 992: 991: 939: 917: 900:Ann Intern Med 886: 837: 820: 800: 769: 718: 677: 651: 640: 556: 499: 473: 472: 470: 467: 450: 447: 432: 431: 428: 413: 410: 404: 401: 395: 392: 360: 357: 343: 340: 328:lipid profiles 319: 316: 273:that causes a 258: 255: 196: 193: 100:LAL deficiency 91: 90: 87: 83: 82: 73: 67: 66: 54: 53: 45: 44: 42:Wolman disease 39: 35: 34: 26: 9: 6: 4: 3: 2: 2328: 2317: 2314: 2312: 2309: 2307: 2304: 2302: 2301:Rare diseases 2299: 2298: 2296: 2281: 2273: 2271: 2267: 2263: 2261: 2253: 2251: 2243: 2241: 2233: 2232: 2229: 2223: 2220: 2216: 2213: 2212: 2211: 2208: 2206: 2203: 2201: 2198: 2196: 2193: 2191: 2188: 2186: 2185:Public health 2183: 2181: 2178: 2176: 2173: 2171: 2168: 2166: 2165:Allied health 2163: 2161: 2158: 2157: 2155: 2151: 2143: 2140: 2139: 2138: 2135: 2133: 2130: 2128: 2125: 2123: 2120: 2118: 2115: 2113: 2110: 2108: 2105: 2103: 2100: 2099: 2097: 2095: 2089: 2077: 2074: 2073: 2072: 2069: 2067: 2064: 2062: 2059: 2057: 2054: 2050: 2047: 2046: 2045: 2042: 2040: 2037: 2035: 2032: 2028: 2025: 2024: 2023: 2020: 2018: 2015: 2013: 2010: 2007: 2004: 2002: 1999: 1995: 1992: 1991: 1990: 1987: 1985: 1982: 1980: 1977: 1975: 1974:Oral medicine 1972: 1970: 1969:Ophthalmology 1967: 1965: 1962: 1958: 1955: 1954: 1953: 1950: 1948: 1945: 1943: 1940: 1938: 1935: 1933: 1930: 1928: 1924: 1921: 1919: 1916: 1912: 1909: 1908: 1907: 1904: 1902: 1899: 1897: 1894: 1892: 1889: 1887: 1884: 1880: 1877: 1875: 1872: 1871: 1870: 1867: 1865: 1862: 1860: 1857: 1856: 1854: 1850: 1842: 1839: 1837: 1834: 1832: 1831:Cytopathology 1829: 1827: 1824: 1822: 1819: 1817: 1814: 1813: 1812: 1809: 1805: 1802: 1800: 1797: 1795: 1792: 1791: 1790: 1787: 1786: 1784: 1782: 1778: 1772: 1771:Urogynecology 1769: 1767: 1764: 1762: 1759: 1757: 1754: 1752: 1749: 1747: 1744: 1743: 1741: 1739: 1733: 1727: 1724: 1722: 1719: 1717: 1714: 1712: 1709: 1707: 1704: 1702: 1699: 1697: 1694: 1692: 1689: 1685: 1682: 1681: 1680: 1677: 1675: 1674:Endocrinology 1672: 1670: 1667: 1665: 1662: 1660: 1656: 1653: 1652: 1650: 1648: 1642: 1636: 1633: 1629: 1626: 1625: 1624: 1621: 1619: 1616: 1614: 1611: 1609: 1606: 1604: 1601: 1599: 1596: 1594: 1591: 1584: 1583: 1582: 1579: 1577: 1574: 1572: 1569: 1567: 1564: 1562: 1559: 1555: 1552: 1550: 1547: 1546: 1545: 1542: 1540: 1537: 1535: 1532: 1530: 1527: 1525: 1522: 1521: 1519: 1517: 1513: 1510: 1508: 1502: 1498: 1494: 1487: 1482: 1480: 1475: 1473: 1468: 1467: 1464: 1452: 1449: 1446: 1442: 1438: 1435: 1433: 1430: 1429: 1427: 1423: 1417: 1414: 1412: 1409: 1407: 1404: 1403: 1401: 1399: 1395: 1385: 1381: 1378: 1377: 1375: 1373: 1368: 1363: 1359: 1356: 1354: 1351: 1349: 1345: 1342: 1340: 1335: 1332: 1331: 1330: 1325: 1320: 1314: 1310: 1307: 1304: 1301: 1299: 1295: 1292: 1291:phospholipid: 1288: 1287:Sphingomyelin 1285: 1284: 1282: 1280: 1279:sphingomyelin 1275: 1269: 1265: 1262: 1261: 1259: 1257: 1252: 1245: 1242: 1240: 1237: 1235: 1231: 1228: 1226: 1222: 1219: 1218: 1216: 1213: 1208: 1203: 1200: 1197: 1192: 1188: 1183: 1179: 1175: 1174:Inborn errors 1171: 1164: 1159: 1157: 1152: 1150: 1145: 1144: 1141: 1135: 1132: 1130: 1127: 1125: 1122: 1119: 1116: 1115: 1105: 1101: 1100: 1096: 1095: 1092: 1088: 1081: 1077: 1076: 1072: 1070: 1066: 1065: 1061: 1059: 1055: 1054: 1050: 1048: 1044: 1043: 1039: 1035: 1033: 1029: 1025: 1024: 1020: 1016: 1015: 1012: 1007: 1003: 987: 983: 979: 975: 971: 967: 963: 959: 955: 951: 943: 927: 921: 913: 909: 905: 901: 897: 890: 882: 876: 868: 864: 860: 856: 852: 848: 841: 835: 834:Who Named It? 831: 830: 824: 818: 814: 809: 807: 805: 788: 784: 778: 776: 774: 765: 761: 756: 755:11577/3168673 751: 746: 741: 737: 733: 729: 722: 714: 710: 705: 700: 696: 692: 688: 681: 674: 668: 666: 664: 662: 660: 658: 656: 649: 644: 636: 632: 627: 622: 617: 612: 608: 604: 600: 593: 591: 589: 587: 585: 583: 581: 579: 577: 575: 573: 571: 569: 567: 565: 563: 561: 552: 548: 543: 538: 533: 528: 524: 520: 516: 508: 506: 504: 488: 484: 478: 474: 466: 464: 460: 456: 446: 444: 440: 435: 429: 426: 425: 424: 421: 419: 409: 400: 391: 389: 385: 381: 377: 373: 370: 366: 356: 354: 350: 339: 335: 333: 329: 325: 315: 311: 309: 308:malabsorption 304: 300: 296: 292: 291:triglycerides 288: 284: 280: 276: 272: 268: 264: 254: 252: 248: 244: 240: 236: 235:malabsorption 231: 229: 225: 221: 220:adrenal gland 217: 216:calcification 213: 209: 204: 202: 192: 190: 186: 182: 177: 175: 174:liver failure 171: 167: 163: 159: 155: 154:malabsorption 151: 146: 144: 143:blood vessels 140: 136: 132: 128: 127:triglycerides 124: 120: 116: 112: 109: 105: 101: 97: 88: 84: 81: 77: 74: 72: 68: 64: 60: 57:LAL-D has an 55: 51: 46: 43: 40: 36: 31: 19: 2190:Rural health 2175:Nanomedicine 1726:Rheumatology 1657: / 1576:Hand surgery 1561:Neurosurgery 1440: 1329:sulfatidoses 1290: 1097: 1073: 1062: 1051: 1036: 1017: 956:(1): 21–27. 953: 949: 942: 932:December 10, 930:. Retrieved 920: 903: 899: 889: 875:cite journal 853:(3): 282–6. 850: 846: 840: 827: 823: 793:December 10, 791:. Retrieved 787:the original 735: 731: 721: 694: 690: 680: 643: 609:(1): 21–30. 606: 602: 525:(1): 21–30. 522: 518: 491:. Retrieved 489:. 2016-03-21 486: 477: 452: 436: 433: 422: 418:Moshe Wolman 415: 406: 403:Epidemiology 397: 382: 378: 374: 362: 345: 336: 321: 312: 278: 260: 232: 205: 198: 178: 147: 103: 99: 95: 94: 41: 2260:Wikiproject 2049:Venereology 1994:Neonatology 1891:Dermatology 1746:Gynaecology 1738:gynaecology 1721:Pulmonology 1539:Eye surgery 1501:Specialties 1372:sphingosine 1221:Ganglioside 1207:ganglioside 626:2318/154122 542:2318/154122 437:In 2015 an 299:cholesterol 269:. It is an 86:Usual onset 63:inheritance 61:pattern of 38:Other names 2295:Categories 2022:Psychiatry 2008:(PM&R) 2001:Phlebology 1989:Pediatrics 1816:Anatomical 1781:Diagnostic 1761:Obstetrics 1711:Nephrology 1696:Hematology 1691:Geriatrics 1684:Hepatology 1669:Cardiology 1659:Immunology 1244:AB variant 1075:DiseasesDB 906:(4): 718. 493:2016-03-25 469:References 359:Management 326:and their 212:ultrasound 89:congenital 80:Hepatology 2210:Physician 2094:education 1952:Neurology 1947:Narcology 1811:Pathology 1789:Radiology 1664:Angiology 1628:Andrology 1406:Infantile 1344:Sulfatide 1324:sulfatide 1256:globoside 970:1476-5365 829:synd/3122 416:In 1956, 394:Prognosis 342:Screening 318:Diagnosis 218:) in the 191:in 2016. 158:nutrients 71:Specialty 2240:Category 1716:Oncology 1647:medicine 1645:Internal 1493:Medicine 1380:Ceramide 1196:ceramide 1099:Orphanet 986:19347350 978:18776925 867:13301142 764:26352813 713:23485521 551:24792990 265:that is 228:cachexia 208:jaundice 162:calories 106:) is an 2280:Outline 2250:Commons 2195:Therapy 2092:Medical 1655:Allergy 1623:Urology 1516:Surgery 1069:D015223 635:2479299 412:History 384:Statins 324:anaemia 2270:Portal 2137:MD–PhD 1303:type C 1120:(NORD) 1104:275761 1058:278000 984:  976:  968:  865:  762:  711:  633:  549:  224:anemia 135:spleen 119:enzyme 117:(LAL) 1852:Other 1425:Other 1322:From 1277:From 1254:From 1205:From 1080:31220 1047:272.7 1032:E75.6 1028:E75.5 982:S2CID 257:Cause 189:Japan 131:liver 104:LAL-D 1194:(to 1064:MeSH 1053:OMIM 1042:9-CM 974:PMID 966:ISSN 934:2015 881:link 863:PMID 817:here 795:2015 760:PMID 709:PMID 631:PMID 547:PMID 367:, a 301:and 289:and 279:LIPA 160:and 125:and 1586:ENT 1504:and 1398:NCL 1370:To 1176:of 1038:ICD 1019:ICD 958:doi 908:doi 855:doi 832:at 750:hdl 740:doi 736:373 699:doi 621:hdl 611:doi 607:235 537:hdl 527:doi 523:235 293:in 230:). 172:or 150:fat 139:gut 102:or 2297:: 1925:/ 1382:: 1360:: 1346:: 1311:: 1289:: 1266:: 1223:: 1172:: 1102:: 1078:: 1067:: 1056:: 1045:: 1030:, 1026:: 1023:10 980:. 972:. 964:. 954:43 952:. 904:58 902:. 898:. 877:}} 873:{{ 861:. 851:91 849:. 803:^ 772:^ 758:. 748:. 734:. 730:. 707:. 695:58 693:. 689:. 654:^ 629:. 619:. 605:. 601:. 559:^ 545:. 535:. 521:. 517:. 502:^ 485:. 465:. 441:, 183:, 176:. 137:, 133:, 78:, 1485:e 1478:t 1471:v 1447:) 1443:/ 1439:( 1336:) 1327:( 1305:) 1296:( 1246:) 1232:( 1214:) 1210:( 1198:) 1184:) 1180:( 1162:e 1155:t 1148:v 1040:- 1021:- 1011:D 988:. 960:: 936:. 914:. 910:: 883:) 869:. 857:: 797:. 766:. 752:: 742:: 715:. 701:: 637:. 623:: 613:: 553:. 539:: 529:: 496:. 98:( 65:. 20:)

Index

Cholesterol esterification disorder

autosomal recessive
inheritance
Specialty
Medical Genetics
Hepatology
autosomal recessive
inborn error of metabolism
lysosomal acid lipase
enzyme
cholesteryl esters
triglycerides
liver
spleen
gut
blood vessels
fat
malabsorption
nutrients
calories
failure to thrive
liver dysfunction
liver failure
enzyme replacement therapy
sebelipase alfa
Japan
swelling of the abdomen
jaundice
ultrasound

Text is available under the Creative Commons Attribution-ShareAlike License. Additional terms may apply.

↑